1. Home
  2. BOLT vs DTSS Comparison

BOLT vs DTSS Comparison

Compare BOLT & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • DTSS
  • Stock Information
  • Founded
  • BOLT 2015
  • DTSS 2014
  • Country
  • BOLT United States
  • DTSS China
  • Employees
  • BOLT N/A
  • DTSS N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • DTSS Computer Software: Prepackaged Software
  • Sector
  • BOLT Health Care
  • DTSS Technology
  • Exchange
  • BOLT Nasdaq
  • DTSS Nasdaq
  • Market Cap
  • BOLT 16.8M
  • DTSS 16.5M
  • IPO Year
  • BOLT 2021
  • DTSS N/A
  • Fundamental
  • Price
  • BOLT $5.91
  • DTSS $1.94
  • Analyst Decision
  • BOLT Buy
  • DTSS
  • Analyst Count
  • BOLT 3
  • DTSS 0
  • Target Price
  • BOLT $50.00
  • DTSS N/A
  • AVG Volume (30 Days)
  • BOLT 26.0K
  • DTSS 81.3K
  • Earning Date
  • BOLT 08-12-2025
  • DTSS 05-14-2025
  • Dividend Yield
  • BOLT N/A
  • DTSS N/A
  • EPS Growth
  • BOLT N/A
  • DTSS N/A
  • EPS
  • BOLT N/A
  • DTSS N/A
  • Revenue
  • BOLT $3,638,000.00
  • DTSS $56,255,129.00
  • Revenue This Year
  • BOLT N/A
  • DTSS N/A
  • Revenue Next Year
  • BOLT $24.14
  • DTSS N/A
  • P/E Ratio
  • BOLT N/A
  • DTSS N/A
  • Revenue Growth
  • BOLT N/A
  • DTSS 144.20
  • 52 Week Low
  • BOLT $5.20
  • DTSS $1.63
  • 52 Week High
  • BOLT $15.60
  • DTSS $7.67
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 47.01
  • DTSS 37.85
  • Support Level
  • BOLT $5.52
  • DTSS $1.91
  • Resistance Level
  • BOLT $6.21
  • DTSS $2.15
  • Average True Range (ATR)
  • BOLT 0.33
  • DTSS 0.11
  • MACD
  • BOLT 0.04
  • DTSS -0.02
  • Stochastic Oscillator
  • BOLT 48.67
  • DTSS 11.43

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About DTSS Datasea Inc.

Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.

Share on Social Networks: